NCT07065331 - A Study of Inhaled AZD8630 in Adolescents With Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 11, 2025

Primary Completion Date

September 19, 2025

Study Completion Date

September 19, 2025

Conditions

Asthma

Interventions

DRUG

AZD8630

Single inhaled dose of AZD8630 via dry powder inhaler.

DEVICE

Dry powder inhaler

Single inhaled dose of AZD8630 via dry powder inhaler.

Trial Locations (9)

Research Site, Raleigh

Research Site, Spartanburg

Research Site, Miami Lakes

Research Site, Toledo

Research Site, Lafayette

Research Site, Oklahoma City

Research Site, Boerne

Research Site, Salt Lake City

Research Site, Bakersfield